侨雄国际(00381.HK):要求向公司归还陈君伟名下安徽福老的20%股权
格隆汇3月18日丨侨雄国际(00381.HK)公布,陈君伟已于2020年3月5日致函予董事会,彼表示,由于中国爆发冠状病毒,相关政府仅提供有限服务,而彼仍无法亲身前往政府办公室完成转让及登记注册程序。于该函件中,彼要求公司给予其更多时间完成办理转让及登记程序。
董事会已决定倘陈君伟未能按照承诺于2020年5月底前去往工商行政管理局完成安徽福老20%股权转往公司名下的股权转让,则公司将再次向安徽省望江县人民法院提交民事起诉书以尽快取得法院起诉受理凭证,要求向公司归还陈君伟名下安徽福老的20%股权,以保障及维护公司的合法权益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.